Elias Marina, Sidik Abubakar I, Mironenko Vladimir, Garmanov Sergey, Khavandeev Maxim L, Mohammad Shafii Abdulmajid Ilyas
Department of Cardiothoracic Surgery, RUDN University, Moscow, RUS.
Department of Cardiothoracic Surgery, Bakulev Scientific Center for Cardiovascular Surgery, Moscow, RUS.
Cureus. 2024 Oct 15;16(10):e71549. doi: 10.7759/cureus.71549. eCollection 2024 Oct.
Introduction Type A aortic dissection (TAAD) is a life-threatening condition that often leads to cerebral malperfusion (CM), a severe complication that can result in permanent neurological damage. Traditionally, a cardiopulmonary bypass (CPB) with selective antegrade cerebral perfusion (ACP) is employed during aortic arch reconstruction to protect cerebral circulation. However, the use of CPB carries inherent higher risks, including embolic events, hypothermia, and interrupted cerebral perfusion, especially in patients with CM. This study evaluates an innovative off-pump extra-corporeal ACP technique using an axillo-axillary shunt to provide uninterrupted bihemispheric cerebral perfusion during branch-first stage total aortic arch replacement (BF-TAR) for TAAD with CM; the shunt depends on cardiac contradiction to transfuse blood from the donor axillary artery to the recipient axillary artery, which then flows to through the carotid and vertebral arteries to the brain. Methods Between 2021 and 2023, 18 patients with TAAD complicated by CM underwent BF-TAR; the novel axillo-axillary shunt technique was employed for ACP because of the risks of ischemic neurologic injury. Outcomes measured included operative mortality, neurological complications, cardiopulmonary bypass times (measured after completion of the branch-first stage), and overall morbidity. Results The axillo-axillary shunt provided stable, continuous ACP in all patients. No new permanent neurological deficits were observed. Five (27.8%) patients experienced transient neurological symptoms such as blurred vision, dizziness, and confusion, which resolved within 48 hours. Operative mortality was 5.6% (1 patient), and minor complications included transitory lower limbs ischemia in 3 patients (16.7%) and deep sternal wound infection in 1 patient (5.6%). All transitory complications were managed by "watchful waiting". The mean CPB time was 145.3 ± 48.6 minutes, while the mean cross-clamp time was 100.6 ± 17.4 minutes, which was better than the average of 227 ± 32 minutes and 147 ± 23 minutes reported in other studies. Postoperative imaging confirmed well-reconstructed aortic arches with no residual malperfusion or graft-related complications. Conclusion The off-pump axillo-axillary shunt technique provides a safe and effective method for maintaining continuous bihemispheric cerebral perfusion during total aortic arch replacement in patients with TAAD complicated by CM. This approach minimizes the risks associated with CPB, including embolic events and interrupted cerebral perfusion while achieving favorable neurological and surgical outcomes. Further studies with larger cohorts and longer follow-ups are warranted to validate the long-term benefits of this innovative technique.
A型主动脉夹层(TAAD)是一种危及生命的疾病,常导致脑灌注不良(CM),这是一种严重并发症,可导致永久性神经损伤。传统上,在主动脉弓重建期间采用体外循环(CPB)结合选择性顺行脑灌注(ACP)来保护脑循环。然而,CPB的使用存在固有的更高风险,包括栓塞事件、体温过低和脑灌注中断,尤其是在患有CM的患者中。本研究评估了一种创新的非体外循环体外ACP技术,该技术使用腋-腋分流术在分支优先阶段全主动脉弓置换(BF-TAR)治疗合并CM的TAAD期间提供不间断的双半球脑灌注;该分流术依靠心脏矛盾运动将血液从供体腋动脉输注到受体腋动脉,然后血液通过颈动脉和椎动脉流向大脑。
2021年至2023年期间,18例合并CM的TAAD患者接受了BF-TAR;由于存在缺血性神经损伤风险,采用了新型腋-腋分流技术进行ACP。测量的结果包括手术死亡率、神经并发症、体外循环时间(在分支优先阶段完成后测量)和总体发病率。
腋-腋分流术在所有患者中均提供了稳定、持续的ACP。未观察到新的永久性神经功能缺损。5例(27.8%)患者出现短暂性神经症状,如视力模糊、头晕和意识混乱,这些症状在48小时内缓解。手术死亡率为5.6%(1例患者),轻微并发症包括3例患者(16.7%)出现短暂性下肢缺血和1例患者(5.6%)出现深部胸骨伤口感染。所有短暂性并发症均通过“密切观察”进行处理。平均体外循环时间为145.3±48.6分钟,而平均主动脉阻断时间为100.6±17.4分钟,优于其他研究报告的平均227±32分钟和147±23分钟水平。术后影像学检查证实主动脉弓重建良好,无残余灌注不良或与移植物相关的并发症。
非体外循环腋-腋分流技术为合并CM的TAAD患者在全主动脉弓置换期间维持持续的双半球脑灌注提供了一种安全有效的方法。这种方法将与CPB相关的风险降至最低,包括栓塞事件和脑灌注中断,同时实现了良好的神经和手术结果。有必要进行更大样本量和更长随访时间的进一步研究,以验证这种创新技术的长期益处。